It started with a kit

It started with a kit Spun-off from Düsseldorf University almost 25 years ago, Qiagen has become the world's leading provider of sample technologies and a top player in molecular diagnostics. By Claudia Eberhard-Metzger Device production at Qiagen: The assembly of prefabricated components into Qiagen spin columns that are used for sample preparation. The machine can produce up to five million spin columns a year. © Jens Willebrand

Written byClaudia Eberhard-Metzger
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

By Claudia Eberhard-Metzger

"What you need is something you can throw away!"

At first thought, such a statement seems an unlikely premise to model a successful company on. It was the summer of 1986, and the advice was given to a young European scientist with a good idea but little experience of market requirements. It came from Michael Hunkapiller, head of research at the California firm Applied Biosystems, and it turned out to be absolutely spot-on.

The young scientist, Metin Colpan, took the counsel of his experienced colleague to heart. On the flight back to Germany he began revising his ideas for a new product. Colpan's idea was to place the materials needed for isolating and purifying nucleic acids into small plastic vessels instead of the stainless steel columns that were currently used. Miniaturization might solve all the problems besetting the nucleic acid isolation and purification in one go. A ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies